Pilot HPV Vaccination in Chinese American Community

HPV Clinical Trial

Official title:

Developing and Pilot Testing a Multilevel HPV Vaccination Intervention in Chinese American Community

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04505930
• Other study ID #: Pilot HPV Vaccination
• Secondary ID: U54CA153513
• Status: Completed
• Phase: N/A
• Start date: April 27, 2015
• Est. completion date: August 31, 2017

Study information

• Verified date: April 2023
• Source: Temple University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study provides a pioneer model in increasing knowledge of HPV vaccination among Chinese American families through culturally tailored interventions, and eventually increase the HPV vaccine uptake among Chinese American adolescents.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 170
• Est. completion date: August 31, 2017
• Est. primary completion date: August 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 110 Years

Eligibility

Inclusion Criteria:

1. Self-identified Chinese Parents or legal guardian with children aged 11-18 years old;

2. The children have not received any does of HPV vaccination Exclusion Criteria: -

Related Conditions & MeSH terms

• HPV

Intervention

Behavioral:
• Interventional HPV vaccination video modules
The study team provide participants in the intervention group with interventional education, using interactive video watch and dynamic discussion. The educational videos were aiming to reinforcement and improvement the awareness, knowledge, attitude, intention and actual uptake of HPV vaccination shots among Chinese parents.
• General Vaccination Education
Education session conducted using only handouts of vaccinations including HPV

Locations

Country	Name	City	State
United States	Center for Asian Health, Lewis Katz School of Medicine, Temple University	Philadelphia	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
Temple University	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	changes from baseline HPV vaccine uptake rate at 6-month follow up	the rate of getting HPV vaccination uptake 6 months post intervention	baseline, and 6-month follow up
Secondary	change of HPV knowledge from baseline to 6-month follow up	Knowledge scores ranged from 0 to 7, computed by taking the total number of correct answers to the questions with a higher numeric value indicating better knowledge	baseline, and 6-month
Secondary	change in adolescents engagement percentage	change in the percents of engaging adolescents in decision-making at post intervention	baseline, and 6-month